| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(88)90219-X |
| P698 | PubMed publication ID | 2972386 |
| P2093 | author name string | M Suemura | |
| T Kishimoto | |||
| T Tanaka | |||
| R Sato | |||
| A Yokota | |||
| Hitoshi Kikutani | |||
| Tetsuji Tanaka | |||
| Akira Yokota | |||
| Ryoichi Sato | |||
| Tadamitsu Kishimoto | |||
| H Kikutani | |||
| E L Barsumian | |||
| Masaki Suemura | |||
| Edward L. Barsumian | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 611-8 | |
| 611-618 | |||
| P577 | publication date | 1988-11-01 | |
| 1988-11-18 | |||
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression | |
| Two species of human Fcε receptor II (FcεRIICD23): Tissue-specific and IL-4-specific regulation of gene expression | |||
| P478 | volume | 55 |
| Q30442853 | A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases |
| Q33884014 | A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent |
| Q38328774 | Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA |
| Q34044904 | Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component |
| Q41990281 | Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells |
| Q72677270 | Allergen-induced CD23 on CD4+ T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation |
| Q34394208 | AllergoOncology: the role of IgE-mediated allergy in cancer |
| Q72650413 | Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element |
| Q41513560 | Alternative transcripts of the human CD23/Fc epsilon RII. A possible novel mechanism of generating a soluble isoform in the type-II cell surface receptor |
| Q37085579 | An update on human CD23 (FcepsilonRII). FcepsilonRII and IgE-BFs (soluble CD23) play an essential role in the regulation of human IgE synthesis |
| Q77969610 | Anti-CD23 monoclonal antibody inhibits germline Cepsilon transcription in B cells |
| Q36284905 | Anti-CD23. |
| Q67508108 | Anti-inflammatory effects of nedocromil sodium: inhibition of alveolar macrophage function |
| Q39108744 | Anti-retroviral antibody FcγR-mediated effector functions |
| Q36631472 | Antibody-mediated antigen sampling across intestinal epithelial barriers |
| Q40993804 | Binding of anti-CD23 monoclonal antibody to the leucine zipper motif of FcepsilonRII/CD23 on B cell membrane promotes its proteolytic cleavage. Evidence for an effect on the oligomer/monomer equilibrium |
| Q34304202 | Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins |
| Q41022608 | CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease |
| Q35350379 | CD23 and eosinophils |
| Q41019661 | CD23 antigen regulation and signaling in chronic lymphocytic leukemia |
| Q72558493 | CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients |
| Q34583137 | CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids |
| Q37660379 | CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells. |
| Q40245183 | CD23-mediated transport of IgE/immune complexes across human intestinal epithelium: role of p38 MAPK. |
| Q41376415 | CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution. |
| Q47889752 | CD23/Fc epsilon RII: signaling and clinical implication |
| Q28315285 | CD23/FcεRII: molecular multi-tasking |
| Q35191872 | CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells |
| Q38800276 | CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation. |
| Q67903884 | Cell-bound IgE and increased expression of Faɛ-receptors on dendritic cells in cutaneous infiltrates of mycosis fungoides |
| Q93531067 | Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors |
| Q74485918 | Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR |
| Q40898757 | Characterization of novel FcepsilonRII/CD23 isoforms lacking the transmembrane (TM) segment in human cell lines |
| Q38292526 | Characterization of the Interleukin-4 Nuclear Activated Factor/STAT and Its Activation Independent of the Insulin Receptor Substrate Proteins |
| Q34418252 | Complement and Fc-receptors in regulation of the antibody response |
| Q37599988 | Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist |
| Q63247615 | Cytokine regulation of low-affinity IgE receptor (CD23) on monocytes from asthmatic subjects |
| Q45775845 | Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS). |
| Q41611054 | Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes |
| Q67900995 | Detection of circulating FcɛR2/CD23+ monocytes in patients with rheumatic diseases |
| Q43181485 | Detection of true IgE-expressing mouse B lineage cells |
| Q40460164 | Differential role for CD23 splice forms in apical to basolateral transcytosis of IgE/allergen complexes. |
| Q92443873 | Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease |
| Q53313488 | Diversification of IgG effector functions. |
| Q35881985 | Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus |
| Q40041854 | Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes. |
| Q38304806 | EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. |
| Q45855126 | Early events in Epstein-Barr virus infection of human B lymphocytes |
| Q43987644 | Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes |
| Q49213098 | Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells |
| Q35181492 | Eosinophil IgE receptor and CD23 |
| Q24675377 | Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI |
| Q36806063 | Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 |
| Q36797190 | Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element |
| Q28276199 | Essential role of Stat6 in IL-4 signalling |
| Q41704731 | Expression of Human Recombinant CD23 in Insect Cells |
| Q67666315 | Expression of on peripheral blood macrophages/monocytes in Kawasaki disease |
| Q36403991 | Expression, Structure, and Function of the CD23 Antigen |
| Q28188153 | Expression, regulation and function of human FcεRII (CD23) antigen |
| Q24291205 | Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts |
| Q70229500 | Failure to detect deposition of complement and immunoglobulin in allergen-induced late-phase skin reaction in atopic subjects |
| Q35350397 | Fc epsilon RII/CD23 on epidermal Langerhans' cells |
| Q44324678 | Fc epsilon receptor II/CD23-positive lymphocytes in atopic dermatitis. I. The proportion of Fc epsilon RII+ lymphocytes correlates with the extent of skin lesion |
| Q37128788 | Fc epsilon receptors |
| Q47945550 | Fcγ Receptor Function and the Design of Vaccination Strategies |
| Q38615357 | Fcγ receptor pathways during active and passive immunization |
| Q47707683 | From allergy to schistosomes: role of Fc receptors and adhesion molecules in eosinophil effector function |
| Q36819988 | Function and regulation of Fc epsilon RI expression on monocytes from non-atopic donors |
| Q37552028 | Functional and clinical consequences of Fc receptor polymorphic and copy number variants. |
| Q24560559 | Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation |
| Q67901956 | Gamma-Interferon Promotes the Release of IgE-Binding Factors (Soluble CD23) by Human Epidermal Langerhans Cells |
| Q72347669 | Granulocyte-macrophage colony-stimulating factor stimulates macrophages to respond to IgE via the low affinity IgE receptor (CD23) |
| Q43835154 | Heterogeneous expression of CD23 epitopes by eosinophils from patients. Relationships with IgE-mediated functions |
| Q42043725 | High affinity targeting of CD23 inhibits IgE synthesis in human B cells |
| Q35695770 | Human antibody effector function |
| Q38307929 | Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with an interferon-gamma-induced nuclear binding factor |
| Q50335919 | IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes |
| Q45046377 | IL-4 induced CD23 (FcepsilonRII) up-regulation in equine peripheral blood mononuclear cells and pulmonary alveolar macrophages |
| Q41065310 | IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII). |
| Q36441745 | Immortalizing Genes of Epstein-Barr Virus |
| Q41504931 | Immunoreceptor tyrosine-based inhibition motifs |
| Q37253272 | Immunoregulation by interleukin-4 in man. |
| Q73469868 | In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain |
| Q28569958 | Increased expression of cytosolic phospholipase A2, 5-lipoxygenase and 5-lipoxygenase-activating protein in rat peritoneal macrophages during ovalbumin-induced sensitization |
| Q42754997 | Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. |
| Q33787602 | Induction and regulation of the IgE response |
| Q41858846 | Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon |
| Q36248937 | Inflammation and the allergic response |
| Q41757368 | Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc epsilon RII monoclonal antibodies |
| Q35752742 | Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of J |
| Q67676596 | Interleukin 4 down-regulates the expression of CD14 in normal human monocytes |
| Q69742436 | Interleukin 4 induces synthesis of IgE and IgG4 in human B cells |
| Q71071170 | Interleukin-4 and low-affinity receptor for IgE on B cells in peripheral blood of patients with atopic bronchial asthma |
| Q73064589 | Interleukin-4 is a pleotropic cytokine with effects on B-cell malignancies |
| Q71815095 | Interleukin‐10 inhibits IgE‐mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes |
| Q40336626 | Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes |
| Q24671741 | Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4 |
| Q53450213 | Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL. |
| Q35548509 | Lymphocyte Fc receptors: the immunobiology and pathology of CD23 |
| Q40681345 | Mechanisms of the human allergic response. Clinical implications. |
| Q41718399 | Modulation of cellular gene expression in B lymphoma cells followingin vitro infection by Epstein-Barr virus (EBV) |
| Q36464514 | Molecular basis for Epstein-Barr virus induced pathogenesis and disease |
| Q40602173 | Molecular basis of Fc receptor function |
| Q24305317 | Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII) |
| Q38676578 | Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future |
| Q53180446 | Monoclonal antibodies to equine CD23 identify the low-affinity receptor for IgE on subpopulations of IgM+ and IgG1+ B-cells in horses. |
| Q44081612 | Mononuclear cell-bound CD23 is elevated in both atopic dermatitis and psoriasis |
| Q34110996 | Multiple facets of intestinal permeability and epithelial handling of dietary antigens |
| Q35232767 | Multiple intracellular signalling pathways triggered by ligation of CD23 (Fc epsilon RII). |
| Q44210321 | Necessity of the stalk region for immunoglobulin E interaction with CD23. |
| Q37717264 | Neutrophils, leukotrienes and bacteria |
| Q42771088 | Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells |
| Q40649997 | Pax‐5 is a key regulator of the B cell‐restricted expression of the CD23a isoform |
| Q35592520 | Prolegomenon for chronic lymphocytic leukaemia |
| Q37964490 | Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application. |
| Q93515051 | Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4 |
| Q28300257 | Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia |
| Q74485763 | Regulation of CD23 isoforms on B-chronic lymphocytic leukemia |
| Q69500120 | Regulation of IgE synthesis in humans |
| Q41126107 | Regulation of IgE synthesis. Lessons from the study of IgE transgenic and CD23-deficient mice |
| Q36116253 | Regulation of antibody production mediated by Fc gamma receptors, IgG binding factors, and IgG Fc-binding autoantibodies |
| Q41200667 | Regulation of human IgE synthesis |
| Q68411976 | Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma |
| Q34251749 | Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome |
| Q35181370 | Regulation of the expression of murine α- and β-FcγR genes |
| Q68726086 | Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni |
| Q72105063 | Requirement of Tyrosine Phosphorylation for Rapid Activation of a DNA Binding Factor by IL-4 |
| Q40403592 | Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells |
| Q35765095 | Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptors |
| Q73539213 | STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia |
| Q35500689 | Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans |
| Q68529112 | Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE |
| Q34066000 | Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia. |
| Q46413567 | Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge |
| Q36043674 | Soluble CD23 controls IgE synthesis and homeostasis in human B cells. |
| Q53545743 | Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. |
| Q44661098 | Soluble FcϵR II levels in normal children and patients with immunodeficiency diseases |
| Q93517917 | Soluble fragments of the low-affinity IgE receptor (CD23) inhibit the spontaneous migration of U937 monocytic cells: neutralization of MIF-activity by a CD23 antibody |
| Q41621374 | Spontaneous and ligand-induced endocytosis of CD23 (Fc epsilon receptor II) from the surface of B lymphocytes generates a 16-kDa intracellular fragment |
| Q36801839 | Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. |
| Q47889764 | Structure and functions of CD23. |
| Q51139019 | Switching capacity of Fc epsilon RII-positive and -negative murine B cells. |
| Q27002843 | Targeting the Fc receptor in autoimmune disease |
| Q59081462 | The B-cell binding site on human immunoglobulin E |
| Q34133992 | The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes |
| Q28207529 | The CD23b promoter is a target for NF-AT transcription factors in B-CLL cells |
| Q58283297 | The Molecular Genetics of Atopy |
| Q39088502 | The Role and Function of Fcγ Receptors on Myeloid Cells |
| Q28590703 | The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice |
| Q40774727 | The biology and pathology of Fc receptors |
| Q34508253 | The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells? |
| Q67901400 | The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: Comparison with their normal cellular counterparts |
| Q36971361 | The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. |
| Q35312671 | The low-affinity receptor for IgE |
| Q40928458 | The nuclear factor IL-4 (NF-IL4). |
| Q37868108 | The receptor for the Fc region of IgE. |
| Q38337679 | The use of in situ hybridization histochemistry for the analysis of neurotransmitter receptor expression at the microscopic level |
| Q35199958 | Traditional Chinese medicine in dermatology |
| Q74630177 | Traditional Chinese medicine in dermatology |
| Q41568143 | Tumour necrosis factor-alpha augments the expression of Fc IgE receptor (Fc epsilon RII/CD23) on human monocytic cell lines and down-regulates interleukin-4-driven Fc epsilon RII expression on monocytes |
| Q37040830 | Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains |
| Q41564429 | β2‐Adrenoceptor stimulation augments the IL‐4‐induced CD23 expression and release and the expression of differentiation markers (CD14, CD18) by the human monocytic cell line, U 937 |
Search more.